Allscripts Healthcare : 2022 Investor Day Presentation

Investor Day

Allscripts/Veradigm

September 28, 2022

Copyright ©2022 Veradigm® | All rights reserved

1

Allscripts| Forward-Looking Statements

This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on the current beliefs and expectations of Allscripts management, only speak as of the date that they are made and are subject to significant risks and uncertainties. Such statements can be identified by the use of words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "can," "may," "look forward," "pipeline" and similar terms. Actual results could differ significantly from those set forth in the forward-looking statements and reported results should not be considered an indication of future performance or events.

Certain factors that could cause our actual results to differ materially from those described in the forward-looking statements include, but are not limited to: our use of the proceeds from the sale of our Hospitals and Large Physician Practices Business; our ability to achieve the margin targets associated with our profitability initiatives within the contemplated time periods, if at all; the continued impact of the COVID-19 pandemic; security breaches resulting in unauthorized access to our or our clients' computer systems or data, including denial-of-services, ransomware or other Internet-based attacks; the failure by Practice Fusion to comply with the terms of the settlement agreements with the U.S. Department of Justice (the "DOJ"); the costs and burdens of compliance by Practice Fusion with the terms of its settlement agreements with the DOJ; additional investigations and proceedings from governmental entities or third parties other than the DOJ related to the same or similar conduct underlying the DOJ's investigations into Practice Fusion's business practices; our ability to recover from third parties (including insurers) any amounts paid in connection with Practice Fusion's settlement agreements with the DOJ and related inquiries; the expected financial results of businesses acquired by us; the successful integration of businesses acquired by us; the anticipated and unanticipated expenses and liabilities related to businesses acquired by us, including the civil investigation by the U.S. Attorney's Office involving our Enterprise Information Solutions business; other risks associated with investments and acquisitions; risks associated with disposition of the Hospitals and Large Physicians Practices Business, our failure to compete successfully; consolidation in our industry; current and future laws, regulations and industry initiatives; increased government involvement in our industry; the failure of markets in which we operate to develop as quickly as expected; our or our customers' failure to see the benefits of government programs; changes in interoperability or other regulatory standards; our ability to maintain and expand our business with existing clients or effectively transition clients to newer products; the effects of the realignment of our sales, services and support organizations; market acceptance of our products and services; the unpredictability of the sales and implementation cycles for our products and services; our ability to manage future growth; our ability to introduce new products and services; our ability to establish and maintain strategic relationships; risks associated with investments and acquisitions; the performance of our products; our ability to protect our intellectual property rights; the outcome of legal proceedings involving us; our ability to hire, retain and motivate key personnel; performance by our content and service providers; liability for use of content; price reductions; our ability to license and integrate third-party technologies; risks related to global operations; variability of our quarterly operating results; risks related to our outstanding indebtedness; changes in tax rates or laws; business disruptions; our ability to maintain proper and effective internal controls; and asset and long-term investment impairment charges. Additional information about these and other risks, uncertainties, and factors affecting our business is contained in our filings with the Securities and Exchange Commission, including under the caption "Risk Factors" in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Qs. We do not undertake to update forward-looking statements to reflect changed assumptions, the impact of circumstances or events that may arise after the date of the forward-looking statements, or other changes in our business, financial condition or operating results over time.

Copyright ©2022 Veradigm® | All rights reserved

2

Copyright ©2022 Veradigm® | All rights reserved

3

Agenda

	Rick Poulton	Introduction
	C H I E F E X E C U T I V E
	O F F I C E R
	Tom Langan	Veradigm Value
	P R E S I D E N T & C H I E F
	C O M M E R C I A L O F F I C E R
	Jonathan Malek	Provider Base Foundation
	S V P & G M , P R O V I D E R
	Jay Bhattacharyya	Payer Connectivity
	S V P & G M , P A Y E R
	Stuart Green	New Perspectives for
	S V P & G M , L I F E S C I E N C E	Biopharma
Leah Jones	Financial Update
	C H I E F F I N A N C I A L O F F I C E R
Copyright ©2022 Veradigm® | All rights reserved	4

Our Mission

Veradigm is a healthcare technology and analytics company spanning across the

three pillars of healthcare

PAY E R P ROVI D ER B I O P HA RM A

Veradigm and the Veradigm Network are different because of our connectivity, scale, and expertise which provides

a uniquely comprehensive scope and depth of interconnected resources, so our clients can drive improved

health outcomes for the patients they serve.

Copyright ©2022 Veradigm® | All rights reserved

5